Aro Biotherapeutics Reports Preliminary Efficacy for ABX1100, a Muscle-targeted GYS1 siRNA, in Patients with Late-Onset Pompe Disease (LOPD)

Aro Biotherapeutics, a clinical-stage biotechnology company developing potent and tissue-targeted short-interfering RNA (siRNA) medicines, today announced interim data from a phase 1b study of ABX1100 ...

Push-Pull Workouts: Definition, Benefits, And How To Add Them To Your Fitness Routine

Prevents fatigue. Alternating between push and pull days allows you to maintain intensity without overtraining and gives your ...
India West

Ram Charan’s New Poster from ‘RRR’ All Muscle and Action

HYDERABAD – After launching the new action-packed poster of Jr NTR on Dec. 6, the makers of ‘RRR’ revealed yet another impressive poster of Ram Charan. The brand new posters unveiled by the makers are ...
Health.com

5 Benefits of Goblet Squats—and How To Do Them Correctly

Mallory Christopherson, DC, FMT, CSCS, is a certified chiropractic and sports medicine physician and founder at Superior Sport & Spine. Goblet squats improve quad strength and increase overall ...
Indiatimes

10 best foods to boost muscle growth and strength

Building muscle and increasing strength isn’t just about spending hours in the gym, what one eats plays an equally critical role. While resistance training provides the stimulus for muscle growth, the ...
Seeking Alpha

Precision BioSciences Announces Late-Breaking Poster Presentation at the 30th Annual International Congress of the World Muscle Society

- Data to highlight latest long-term preclinical efficacy and durability data supporting PBGENE-DMD for the treatment of Duchenne Muscular Dystrophy - - On track to file an IND and/or CTA by the end ...
Yahoo Finance

Precision BioSciences Announces Late-Breaking Poster Presentation at the 30th Annual International Congress of the World Muscle Society

DURHAM, N.C., September 30, 2025--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo ...
The Globe and Mail

Precision BioSciences Announces Late-Breaking Poster Presentation at the 30th Annual International Congress of the World Muscle Society

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
The Globe and Mail

Satellos to Present SAT-3247 Phase 1 Clinical Data in Late-Breaking Poster Session at the 2025 World Muscle Society Congress

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...
Yahoo Finance

Satellos to Present SAT-3247 Phase 1 Clinical Data in Late-Breaking Poster Session at the 2025 World Muscle Society Congress

TORONTO, September 29, 2025--(BUSINESS WIRE)--Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving ...
Stockhouse

Satellos to Present SAT-3247 Phase 1 Clinical Data in Late-Breaking Poster Session at the 2025 World Muscle Society Congress

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines ...